Celularity Inc. Expense Related to Distribution or Servicing and Underwriting Fees
Celularity Inc. (CELU) reported Expense Related to Distribution or Servicing and Underwriting Fees of $5.00 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees · last filed 2021-08-19
- Celularity Inc. expense related to distribution or servicing and underwriting fees for the quarter ending 2021-06-30 was $0.00.
- Celularity Inc. expense related to distribution or servicing and underwriting fees for the quarter ending 2021-03-31 was $5.00M, a 0.00% change year-over-year.
- Celularity Inc. expense related to distribution or servicing and underwriting fees for the quarter ending 2020-12-31 was $0.00.
- Celularity Inc. expense related to distribution or servicing and underwriting fees for the quarter ending 2020-09-30 was $0.00.
- Celularity Inc. expense related to distribution or servicing and underwriting fees for fiscal 2020 was $5.00M, a 0.00% change from fiscal 2019.
- Celularity Inc. expense related to distribution or servicing and underwriting fees for fiscal 2019 was $5.00M.
| Period end | Expense Related to Distribution or Servicing and Underwriting Fees 3 month | Expense Related to Distribution or Servicing and Underwriting Fees 6 month | Expense Related to Distribution or Servicing and Underwriting Fees 9 month | Expense Related to Distribution or Servicing and Underwriting Fees 12 month |
|---|---|---|---|---|
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-19 | $5.00M 10-Q · filed 2021-08-19 | $5.00M derived: sum of 3 quarters · filed 2021-08-19 | $5.00M derived: sum of 4 quarters · filed 2021-08-19 |
| 2021-03-31 | $5.00M 10-Q · filed 2021-05-24 | $5.00M derived: sum of 2 quarters · filed 2021-05-24 | $5.00M derived: sum of 3 quarters · filed 2021-05-24 | $5.00M derived: sum of 4 quarters · filed 2021-05-24 |
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | $0.00 derived: sum of 2 quarters · filed 2021-05-24 | $0.00 derived: sum of 3 quarters · filed 2021-05-24 | $5.00M 10-K/A · filed 2021-05-24 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $5.00M 10-Q · filed 2020-11-16 | $5.00M derived: sum of 4 quarters · filed 2020-11-16 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $5.00M 10-Q · filed 2020-08-13 | $5.00M derived: sum of 3 quarters · filed 2020-08-13 | $5.00M derived: sum of 4 quarters · filed 2020-08-13 |
| 2020-03-31 | $5.00M 10-Q · filed 2020-05-15 | $5.00M derived: sum of 2 quarters · filed 2020-05-15 | $5.00M derived: sum of 3 quarters · filed 2020-05-15 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | $0.00 derived: sum of 2 quarters · filed 2020-03-24 | $5.00M 10-K · filed 2020-03-24 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $5.00M 10-Q · filed 2019-11-13 | ||
| 2019-06-30 | $5.00M 10-Q · filed 2019-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |